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Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated genes (cas) are
widely distributed among bacteria. These systems provide adaptive immunity against mobile genetic elements
specified by the spacer sequences stored within the CRISPR.
Methods
The CRISPR-Cas system has been identified using Basic Local Alignment Search Tool (BLAST) against other
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Reactions (PCR) and Sanger DNA sequencing, we discovered CRISPRs in additional bacterial isolates of the
same species of Bordetella. Transcriptional activity and processing of the CRISPR have been assessed via RT-
PCR.
Results
Here we describe a novel Type II-C CRISPR and its associated genes—cas1, cas2, and cas9—in several
isolates of a newly discovered Bordetella species. The CRISPR-cas locus, which is absent in all other Bordetella
species, has a significantly lower GC-content than the genome-wide average, suggesting acquisition of this
locus via horizontal gene transfer from a currently unknown source. The CRISPR array is transcribed and
processed into mature CRISPR RNAs (crRNA), some of which have homology to prophages found in closely
related species B. hinzii.
Conclusions
Expression of the CRISPR-Cas system and processing of crRNAs with perfect homology to prophages
present in closely related species, but absent in that containing this CRISPR-Cas system, suggest it provides
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system is 990 bp smaller than that of Streptococcus pyogenes, the 4,017-bp allele currently used for genome
editing, and which may make it a useful tool in various CRISPR-Cas technologies.
Keywords
Bordetella pseudohinzii, Type II CRISPR, Cas9, SpyCas9, Bacteria, Genome editing, Protospacer, GC-
content, HGT
Disciplines
Biology | Genetics and Genomics | Genomics
Creative Commons License
Creative
Commons
License
This work is licensed under a Creative Commons Attribution 4.0 License.
This article is available at The Cupola: Scholarship at Gettysburg College: https://cupola.gettysburg.edu/biofac/52
Authors
Yury V. Ivanov, Nikki Shariat, Karen B. Register, Bodo Linz, Israel Rivera, Kai Hu, Edward G. Dudley, and Eric
T. Harvill
This article is available at The Cupola: Scholarship at Gettysburg College: https://cupola.gettysburg.edu/biofac/52
RESEARCH ARTICLE Open Access
A newly discovered Bordetella species
carries a transcriptionally active CRISPR-Cas
with a small Cas9 endonuclease
Yury V. Ivanov1*, Nikki Shariat2,3†, Karen B. Register4†, Bodo Linz1, Israel Rivera1, Kai Hu1, Edward G. Dudley2
and Eric T. Harvill1,5
Abstract
Background: Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated genes (cas)
are widely distributed among bacteria. These systems provide adaptive immunity against mobile genetic elements
specified by the spacer sequences stored within the CRISPR.
Methods: The CRISPR-Cas system has been identified using Basic Local Alignment Search Tool (BLAST) against other
sequenced and annotated genomes and confirmed via CRISPRfinder program. Using Polymerase Chain Reactions (PCR)
and Sanger DNA sequencing, we discovered CRISPRs in additional bacterial isolates of the same species of Bordetella.
Transcriptional activity and processing of the CRISPR have been assessed via RT-PCR.
Results: Here we describe a novel Type II-C CRISPR and its associated genes—cas1, cas2, and cas9—in several isolates
of a newly discovered Bordetella species. The CRISPR-cas locus, which is absent in all other Bordetella species, has a
significantly lower GC-content than the genome-wide average, suggesting acquisition of this locus via horizontal gene
transfer from a currently unknown source. The CRISPR array is transcribed and processed into mature CRISPR RNAs
(crRNA), some of which have homology to prophages found in closely related species B. hinzii.
Conclusions: Expression of the CRISPR-Cas system and processing of crRNAs with perfect homology to prophages
present in closely related species, but absent in that containing this CRISPR-Cas system, suggest it provides protection
against phage predation. The 3,117-bp cas9 endonuclease gene from this novel CRISPR-Cas system is 990 bp smaller than
that of Streptococcus pyogenes, the 4,017-bp allele currently used for genome editing, and which may make it a useful
tool in various CRISPR-Cas technologies.
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Background
Clustered regularly interspaced short palindromic repeats
(CRISPR)-Cas (CRISPR-associated) systems serve as an
adaptive immune mechanism in prokaryotes that confer
protection against bacteriophages and other mobile ele-
ments and vectors [1]. A typical CRISPR-cas locus includes
a CRISPR array of containing direct repeats (DR) separated
by spacers (Sp) and adjacent cas genes [2]. In response to
invading DNA, CRISPRs acquire short fragments of the
foreign nucleic acid sequences and insert those as new
spacers at the beginning of the CRISPR array, with each
spacer flanked on both sides by direct repeat sequences.
This acquisition step involves Cas1, Cas2, and Cas9 pro-
teins [3–5]. Cas9, the signature of Type II CRISPR systems
[6], is a RNA-guided endonuclease. CRISPR arrays are tran-
scribed and subsequently processed into small individual
CRISPR RNAs (crRNA). This “maturation” step of the array
precursor requires a trans-activating crRNA (tracrRNA), an
endogenous ribonuclease RNase III, and Cas9 [7, 8]; al-
though RNase-III-independent systems exist for some
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bacteria with Type II-C CRISPRs [9]. In Streptococcus
pyogenes, one of the most well studied Type II CRISPR-Cas
systems, both tracrRNA and crRNA guide the Cas9 endo-
nuclease to a complementary target sequence (protospacer)
to mediate a double-stranded DNA break during target
interference. For additional specificity and to avoid cutting
within the array itself (autoimmunity), RNA-guided Cas9
cleavage requires a protospacer adjacent motif (PAM; in S.
pyogenes: 5′-NGG-3′) flanking the target site. The specific-
ally targeted endonuclease activity of the S. pyogenes Type
II-A CRISPR-Cas system has allowed for important break-
through applications in RNA-guided control of gene
expression, genome engineering, and genome editing of
multiple organisms [7, 10]. But limitations of this particular
system have led to a search for new CRISPR-Cas systems
with altered features.
The publicly available CRISPRfinder program [11] identi-
fied CRISPR-cas loci in 45 % (1176/2612) of the bacterial
genomes analyzed, but CRISPR-Cas systems have not been
identified within the genus Bordetella. This genus, which is
comprised of nine species, is historically subdivided into
“classical” and “non-classical” bordetellae. The extensively
studied classical bordetellae consist of the three respiratory
pathogens: B. pertussis and B. parapertussis, the causative
agents of “whooping cough” in humans, and B. bronchisep-
tica, which causes a broad variety of respiratory disease
in many different mammals. The non-classical bordetellae
are both genotypically and phenotypically different from
the classical bordetellae [12]. They consist of the six
recently described species: B. hinzii, B. holmesii, B.
ansorpii, B. trematum, B. petrii, and B. avium, all of
which are only partially characterized [13–17]. While the
classical bordetellae are usually associated with respiratory
disease, several non-classical species have also been
isolated from wound and ear infection, septicemia and
endocarditis, predominantly from immunocompromised
patients. For example, B. hinzii, which is a respiratory
pathogen in poultry [18] and rodents [19], has also been
isolated from humans with chronic cholangitis [20],
bacteremia [21], or fatal septisemia [22].
We set out to define the sequence diversity within the
Bordetella genus and recently published the genome se-
quences of numerous isolates from several species [23–26].
During these studies, we discovered a novel species that we
named Bordetella pseudohinzii (manuscript in preparation).
This species is a close relative of B. hinzii and naturally
infects laboratory-raised mice. B. hinzii and B. pseudohinzii
are distinguishable based on substantial divergence in
sequence and gene content, as well as the presence of a
CRISPR-Cas system that is unique to the genome of
B. pseudohinzii. Here, we describe this novel CRISPR-Cas
system, demonstrate that it is transcriptionally active and
present evidence that it acts as an adaptive immune system
against mobile genetic elements, including bacteriophage
sequences present in B. hinzii. These data suggest that
both species have recently shared an ecological niche with
phages, which are represented by the prophages in B. hin-
zii genomes and the matching spacers in the genome of
B. pseudohinzii, and that acquisition of this CRISPR-Cas
system protects against those.
Methods
Bacterial strains and culture conditions
Bacterial isolates used in this study are described in
Additional file 1: Table S1. Cultures used for prepar-
ation of DNA were grown at 37 °C on Bordet-Gengou
agar containing 10 % sheep’s blood. Stainer-Scholte
broth cultures inoculated with colonies from Bordet-
Gengou agar and incubated at 37 °C with shaking were
used for RNA purification. Growth in broth culture was
monitored periodically by checking optical density
values (at 600 nm wave length).
DNA isolation, PCR, and sequencing
DNA used for amplification and sequencing of cas
genes and the CRISPR array was purified using a
commercially available kit (Promega) and was quanti-
fied with a Nanodrop 2000 (Thermo Scientific).
Primers for amplification of the complete CRISPR
array and of the cas9, cas1, cas2, and 16S rRNA
genes from other B. pseudohinzii isolates (Additional
file 2: Table S2) were designed based on the genome se-
quence of isolate 8-296-03 [GenBank:JHEP01000084].
PCR reactions included 200 μM of dNTPs, 0.5 μM of each
primer, 1.5 mM of MgCl2, 2 U of Taq polymerase (Roche),
5.0 μl of 10× Buffer II, 10 % DMSO and ~150 ng of puri-
fied DNA template in a final volume of 50 μl. Cycling con-
ditions for the amplification of cas9 were 95 °C for 15 min
and 35 cycles of 95 °C for 30 s, 54 °C for 30 s and 72 °C
for 3 min, followed by a final elongation step of 72 °C
for 4 min. Cycling conditions used with the remaining
primer pairs were identical except that the extension
time was shortened from 3 min to 1 min. PCR ampli-
cons used for sequencing were purified with ExoSAP-
IT (USB Corporation) and sequenced at the National
Animal Disease Center Genomics Unit using Applied
Biosystems Big Dye Terminator v3.1 on an Applied
Biosystems 3130 XL Genetic Analyzer sequencer.
CRISPR-cas locus annotation and protospacer prediction
All Bordetella genome sequences available at GenBank
were searched for the presence of CRISPR systems using
CRISPRFINDER [11]. Predicted spacer sequences were
submitted to BLAST search to query the nucleotide col-
lection (nr/nt) and whole-genome shotgun contigs (wgs)
databases at NCBI. Because E-value is inadequate when
using short nucleotide sequences as BLAST queries, we
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introduce a “percent hit quality” score (% HQ) to iden-
tify and rank the most significant BLAST hits:
%HQ ¼ % cov %ID
100%
;
where %cov represents the percentage of coverage between
the spacer and predicted protospacer sequences and %ID
stands for percent nucleotide identity between the two.
GC-content
The guanine and cytosine content (GC-content) was
calculated within a 120-bp sliding window. The difference
in GC-content between the CRISPR-cas locus and the
genome average was determined using a two-proportion
test implemented in Minitab 17 (www.minitab.com).
Briefly, numbers of G +C (“positive events”) and A +T
(“negative events”) were calculated separately for the
chromosome [GenBank:JHEP01000084] and for the
CRISPR-cas locus. Because the CRISPR array consists of re-
petitive sequences, its GC-content is skewed and, therefore,
the array sequence was not included. The significance of
the difference (P-value) was calculated using two-tailed
Fisher’s exact test.
RNA purification and RT-PCR analysis
Total RNA was isolated from bacterial cultures during loga-
rithmic growth at OD600 = 0.5 and during the stationary
phase after overnight growth using the TRIzol® Plus RNA
Purification System (Life Technologies). To eliminate any
residual DNA in the samples, a DNase treatment was
implemented during RNA extraction, following the manu-
facturer’s protocol. Reverse transcription reactions were
carried out using Superscript III reverse transcriptase (Invi-
trogen), random hexamer primers and 150 ng of total
RNA, following the manufacturer’s instructions. Primers
for the amplification of cas9, cas1, and cas2 gene fragments
(Additional file 2: Table S2) were designed to yield PCR
amplicons of ~100 bp in size (Fig. 1c). The PCR reaction
mixture consisted of 2 μl of cDNA template (150 ng/μl),
0.2 μl of 10-mM dNTP mix, 1 μl of 10-mM forward and
reverse oligonucleotide primer, 0.2 μl of Taq DNA polymer-
ase (1 unit), 2 μl of 10× ThermoPol reaction buffer, and
14.6 μl of ddH2O, in a total volume of 20 μl. Amplification
was carried out at 95 °C for 10 min, followed by 35 cycles
of 95 °C for 30 s, 55 °C for 30 s, and 72 °C for 30 s. A final
extension step was carried out at 72 °C for 8 min. PCR
products were electrophoresed in 2 % agarose gels and
visualized with ethidium bromide under UV-light.
Mature crRNAs were PCR amplified using the Quanti-
Mir RT Kit (Systems Biosciences) following the manufac-
turer’s instructions. Briefly, a poly(A)-tail with an attached
adaptor sequence was ligated to the mRNA transcripts,
and the product was converted to cDNA. crRNAs corre-
sponding to spacers Sp2, Sp3, Sp10, and Sp19 were PCR-
amplified from the resulting cDNA library with primers
(Additional file 2: Table S2) complementary to the attached
adaptor and the individual spacer sequences. The PCR only
yielded amplicons from mature crRNAs but not from the
unprocessed transcript of the CRISPR array. Each PCR
product consisted of a spacer sequence, a flanking part of
the direct repeat and an attached poly(A)-tail with a univer-
sal primer sequence. The expected size of each of the four
tested amplicons is ~85 bp. PCR products were electropho-
resed in 2.8 % agarose gels and visualized with ethidium
bromide under UV-light.
Results
Annotation of the CRISPR-Cas elements and expression
in vitro
The genome of Bordetella pseudohinzii strain 8-296-03
contains three consecutive, apparently co-transcribed,
genes (Fig. 1a) that are homologous to cas9, cas1, and
cas2 of Alicycliphilus denitrificans (Additional file 3:
Figure S1, Additional file 4: Table S3). Upstream of those
genes, a putative tracrRNA is encoded divergently, flanked
by a putative promoter and a rho-independent stem-loop
terminator. Downstream of the cas genes, the CRISPR
array contains 22 direct repeats (DR) and 21 spacer
sequences (Sp). Of these, 19 direct repeats are identical,
one repeat (DR-4) has a single nucleotide polymorphism
(SNP), and the terminal direct repeat (DR-1) has 3 SNPs
(Fig. 1b). While each direct repeat is exactly 36 nucleo-
tides in length, the spacer sequences vary: 19 spacers are
30 nucleotides and two are 29 nucleotides long. The
sequence of each spacer is unique. Based on the presence
and organization of cas9, cas1, and cas2 genes within the
operon, we typed this CRISPR-Cas system as Type II-C,
according to the classification of the CRISPR-Cas systems
established by Makarova et al. [6].
(See figure on previous page.)
Fig. 1 Organization and expression of the Type II-C CRISPR-cas locus of B. pseudohinzii. a Graphical representation of the CRISPR-cas locus. The
red block upstream of the cas9 gene is a putative tracrRNA flanked by the predicted promoter (arrow) and stem-loop terminator (up-side-down
sigma symbol). The CRISPR array is enlarged relative to the cas genes for visual clarity. b Nucleotide sequence of the CRISPR array. SP# is the spacer
sequence number; DR# is the direct repeat number. Nucleotides deviating from the DR consensus in DR-1 and DR-4 are highlighted in red.
c Confirmation of cas9 (C9), cas1 (C1), and cas2 (C2) expression during logarithmic (Log) and stationary phases of growth. Each PCR
amplicon was designed to have a similar size. M: 100-bp DNA ladder. d The CRISPR array is processed into individual, mature crRNAs.
Positive and negative strands are relative to the orientation shown in Fig. 1a. M: 50-bp DNA ladder
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A functional CRISPR-Cas system requires expression
of the cas genes and the CRISPR array, followed by mat-
uration of individual crRNAs. Therefore, we performed
an RT-PCR to test whether the cas genes are transcribed
during growth in vitro. Amplicons of cas9, cas1, and
cas2 were observed from RNA obtained during both
logarithmic and stationary phases of growth (Fig. 1c).
Processing of the precursor CRISPR array transcript into
mature crRNAs was also confirmed by RT-PCR
(Fig. 1d).
To predict putative protospacer targets we submitted
each spacer sequence to BLAST search. Table 1 summa-
rizes hits with >80 % hit quality (HQ). Two spacers, Sp8
and Sp9, are identical to prophage elements found in B.
hinzii. Sp16, Sp10, and Sp20 show high HQ (97 %, 86 %,
and 83 %, respectively) with different prophages found
in B. hinzii and B. bronchiseptica and with a capsid gene
of a Microviridae-family phage (subfamily Gokushoviri-
nae), respectively. Spacer Sp13 matches a transposase of
the IS3/IS911 family with (90 % HQ). Importantly,
several prophages identified as likely sources of spacer
elements are not found in the genome of B. pseudohinzii
8-296-03 but are present in closely related B. hinzii, which
appear to lack a CRISPR-Cas system. Collectively, these
observations suggest that acquisition of the CRISPR-Cas
system by B. pseudohinzii conferred CRISPR-mediated
protection against these bacteriophages and other mobile
genetic elements.
The S. pyogenes Cas9 protein (SpyCas9) contains
RuvC-like and HNH motifs that were shown to be
essential for its function [7]. We searched for both these
motifs in the corresponding Cas9 from B. pseudohinzii
(BpsuCas9) (Additional file 5: Figure S2). The RuvC-like
endonuclease motif showed 80 % amino acid (aa) simi-
larity (47 % aa identity) and the HNH motif had 66 % aa
similarity (33 % aa identity). In each of the motifs, amino
acid residues that are conserved among different type-II
Cas9 proteins and that were shown to be essential for
Cas9 function are identical in BpsuCas9.
Targeted cleavage by Cas9 requires a protopspacer
adjacent motif (PAM), a short sequence, which is 5′-
NGG-3′ in S. pyogenes [7]. We attempted to determine
in silico a possible PAM sequence that is recognized by
BpsuCas9, but the few available protospacer sequences
with a high HQ score (Table 1) limited the number
of potential sequence candidates. Although eight pre-
dicted protospacers and their flanking sequences are
not sufficient to conclusively determine the exact
PAM sequence, we propose 5′-WGR-3′ as a potential
motif used by BpsuCas9 (Additional file 6: Figure S3).
Additional B. pseudohinzii isolates possess the CRISPR-cas
locus
Eleven other isolates identified as B. pseudohinzii on
the basis of their 16S rRNA genes were tested for the
presence of a CRISPR-cas locus. PCR using gene-
specific primers confirmed the presence of cas9, cas1,
and cas2 in all isolates (Fig. 2a-c). A CRISPR array was
also found in all isolates but some variation in size
was observed (Fig. 2d). Sequencing of the CRISPR
array PCR amplicons revealed that their lengths are
affected by the loss of Sp14 in isolate#2, of Sp8 to
Sp11 in isolate#6, and of Sp9 in isolate#10, consistent
with the difference in size observed among amplicons
(Fig. 2d and e). Each missing spacer is accompanied by
the loss of adjacent direct repeat, so that the overall
architecture of the array, (−DR-Sp-)n, remains intact.
The array sequences from all isolates are otherwise
identical to one another (Fig. 2e).
Table 1 Highest-scoring BLASTn hits for spacer sequences
BLASTn Sp# %ID %cov %HQ
Protospacer Locus tag/name Organism
Prophage: hypothetical protein L544_3238 Bordetella hinzii OH87 BAL007II 8 100 100 100
Prophage: intergenic region L544_1114 Bordetella hinzii OH87 BAL007II 9 100 100 100
L544_1115
Prophage: replicative DNA helicase L541_4891 Bordetella hinzii CA90 BAL1384 16 100 97 97
dnaB_2
Mobile element of IS3/IS911 family Transposase Variovorax paradoxus EPS 13 90 100 90
Pyruvate carboxyl transferase C791_4721 Amycolatopsis azurea DSM 43854 6 93 97 90
transfer RNA tRNA-Gly Bifidobacterium asteroides PRL2011 1 93 93 86
Prophage: Siphovirus gp157 BB3535 Bordetella bronchiseptica RB50 10 93 93 86
Phage structural component KF689531.1 Gokushovirinae clone BBHD08n1 20 96 86 83
major capsid
Sp# spacer number, %ID percent nt identity, %cov percent coverage, %HQ percent hit quality
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The insertion site of the CRISPR-Cas system is a recombin-
ation hotspot in Bordetella
Since we found no evidence for a CRISPR-Cas system in
any Bordetella species, suggesting it was acquired solely
by the B. pseudohinzii lineage, we assessed the local
gene organization near the insertion site of the CRISPR-
cas locus in other Bordetella genomes (Fig. 3). Only
B. pseudohinzii and B. hinzii exhibit synteny of both the
upstream dapB—murB—tRNA-Gly gene cluster and the
downstream cluster consisting of a reductase (redoxin)
and a disulfide-isomerase (S2isom). In other species, syn-
teny is conserved only upstream of the point at which the
CRISPR-Cas locus is located in B. pseudohinzii. Genes
downstream vary both in identity and orientation, even
among isolates of the same species (B. bronchiseptica),
suggesting this region is a hotspot for recombination.
Since absence of the CRISPR-Cas system in the
other Bordetella species suggests that it was acquired
via horizontal gene transfer (HGT), we examined
the GC-content of the region including upstream
dapB—murB—tRNA-Gly genes, the CRISPR-cas locus,
and the downstream redoxin-S2isom genes. The GC-
profile of the upstream and downstream genes is consist-
ent with the genome average of 66.5 % (Fig. 4, grey
horizontal line). In contrast, the CRISPR-cas locus has a
GC-content of 56 %, which is significantly lower (two-
tailed Fisher’s exact test, P < 0.01). These data strongly
suggest that the CRISPR-cas locus of B. pseudohinzii has
been horizontally acquired from an unknown source,
likely one with a lower GC-content.
Evolutionary relationship and horizontal gene transfer
The Cas9 protein is a signature feature of all type-II
CRISPR-Cas systems. To identify a possible source of the
B. pseudohinzii CRISPR-Cas system, we performed
BLAST searches for Cas9 protein sequences (Fig. 5). The
Fig. 2 Eleven additional B. pseudohinzii isolates possess the CRISPR-cas locus. PCR amplicons of cas9 (a), cas1 (b), cas2 (c) and the CRISPR array (d) from
12 B. pseudohinzii isolates. Lane 1: isolate 8-296-03; lanes 2–12: sequentially obtained isolates #2 to #12, respectively (Additional file 1: Table S1);
Lane 13: negative control PCR. e Schematic representation of the CRISPR array in each of the isolates. Squares represent spacer sequences. Diamonds
represent direct repeats. Arrows in panel D denote isolates that are missing spacer sequences Sp14 (isolate #2), Sp8 to Sp11 (#6) and Sp9
(#10) in panel e
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two highest-scoring hits, both from Alicycliphilus denitri-
ficans, have 74 % aa identity (Additional file 4: Table S3),
suggesting that the proposed recent acquisition of this
CRISPR-Cas system into the genome of B. pseudohinzii
was probably from an unknown vector. The Cas9-based
phylogeny depicted in Fig. 5 includes the highest-scoring
hits together with a subset of selected Cas9 sequences pre-
viously published elsewhere [27]. Notably, the 5 closest
hits are from related genera, all of which belong to the
order Burkholderiales in the class Betaproteobacteria. Im-
mediately outside of this clade is the Cas9 from other
Betaproteobacteria and from gamma proteobacterium
HdN1. The six-member clade of the Burkholderiales,
including B. pseudohinzii, is not the only occurrence of
Cas9 in the Burkholderiales; Ralstonia syzygii and Oligella
urethralis also belong to this order but possess divergent
Cas9 sequences more closely related to those from a
variety of Alphaproteobacteria (Fig. 5). The presence of
closely related bacteria within several clades of the tree
suggests multiple, independent HGT events associated
with the acquisition of CRISPR systems.
To further explore horizontal acquisition of CRISPR-
Cas systems, we calculated the GC-contents for both the
cas9 gene and the genome for all taxa on the tree. The
cas9 sequences ranged from 73.5 % to 29 % GC-content.
Likewise, the genomes varied in a similar range from
70.7 % to 30.5 % GC-content. However, in several cases
a discrepancy is apparent between the GC-contents of
cas9 and the corresponding genome (Fig. 5b, column Δ).
The largest difference was found in S. pyogenes M1
whose cas9 has a GC-content 24.9 % higher than the
average for the genome. Discrepancy between the 16S-
rRNA-gene tree relating bacterial species and the tree
relating their cas9 gene products suggests horizontal
acquisition of the CRISPR-Cas. Similarly, GC-content
differences between the CRISPR-cas locus and the rest
of the genome further support this HGT.
Discussion
Several lines of evidence suggest that the novel CRISPR-
Cas system described here is functional. We observed active
transcription of cas genes and array sequence, as well
as maturation of the array transcript. Further, the array
contains multiple spacer sequences with homology to
prophages in genomes of the most closely related species,
B. hinzii. Yet, those prophages are absent from B.
Fig. 3 Local gene organization near the insertion site of the B. pseudohinzii CRISPR-cas locus in multiple Bordetella genomes. The genome
synteny is conserved upstream the insertions site, while downstream genes vary in both identity and orientation. Dashed lines denote absence of
sequence as compared to B. pseudohinzii 8-296-03. Genes with the same functional annotations are colored identically. The CRISPR array is shown
schematically with black diamonds for direct repeats and colored rectangles for spacer sequences; the total number of spacers is 21
Fig. 4 The GC-content of the B. pseudohinzii 8-296-03 CRISPR-cas
locus is significantly lower than that of the genome. The grey
horizontal line indicates the average GC-content of 66.5 % for
the genome. White rectangles represent genes. The CRISPR array
is represented by diamonds (♦, direct repeats) and squares (■, spacer
sequences). On the x-axis, 0 corresponds to nucleotide coordinate
24,537 bp of the contig [GenBank:JHEP02000007]
Ivanov et al. BMC Genomics  (2015) 16:863 Page 7 of 10
pseudohinzii, suggesting that the CRISPR-Cas may have
provided protection against them as an adaptive immune
system.
Interestingly, B. hinzii contains prophages and B.
pseudohinzii contains CRISPR-associated spacer se-
quences that perfectly match those prophages. These
observations indicate that both species have been pre-
dated by the same phage and have survived that preda-
tion in these two different ways. Acquisition of the
prophage or the CRISPR-Cas system, either of which
would prevent further phage predation, could have also
accelerated the divergent evolution of B. hinzii and B.
pseudohinzii by differently affecting uptake or loss of
various other genes, contributing to the observed differ-
ences in gene content of these closely related species.
It is often observed that horizontally acquired DNA
has a lower GC-content than the genome that receives
it [28]; and the GC-content of the CRISPR-Cas system
in B. pseudohinzii follows this trend. However, our com-
parison of multiple genomes revealed several cases in
which the GC-content of the acquired CRISPR-Cas sys-
tem is higher than the genome average (Fig. 5). The
most striking example is S. pyogenes whose cas9 gene
is functional and is successfully used in genome
manipulations. This gene has a 25 % higher GC-content
than the genome that contains it, suggesting that S. pyo-
genes acquired its CRISPR-Cas system by HGT and that
substantial differences in GC-content do not prevent
the function of the Cas9 protein.
Recent advances in genome editing, genome engineer-
ing, and transcriptional control of genes in multiple
organisms take advantage of the endonuclease SpyCas9.
However, an important limitation of SpyCas9 is its size.
The S. pyogenes cas9 allele measures 4,107 base pairs, a
size that stretches the carrying capacities of some
commonly employed vectors. To address this problem,
a recent paper described the use of a 3,159-bp gene
encoding Cas9 from Staphylococcus aureus (SaCas9),
which recognizes a different PAM sequence (5′-
NNGRR-3′) [29]. We introduce BpsuCas9, which is of a
similarly small size (3,117 bp) and employs a PAM con-
sensus sequence that putatively consists of 5′-WGR-3′
(Additional file 6: Figure S3) and may provide further
flexibility with regards to designing guide RNAs. Future
experiments will determine the specific features of the
B. pseudohinzii CRISPR-Cas system and its potential
utility as an additional or alternative tool for genome
editing and other applications.
Fig. 5 Cas9-based phylogeny and GC-content of B. pseudohinzii and the highest-scoring BLAST hits. a Maximum likelihood tree based on Cas9
proteins. The green rectangle outlines taxa from the order Burkholderiales. Taxa are colored according to their class-level taxonomic assignment:
Gammaproteobacteria in black, Bacilli in red, Betaproteobacteria in blue, Alphaproteobacteria in purple, Bacteroidia in orange, Flavobacteriia in
golden, Epsilonproteobacteria in grey, Clostridia in green, Actinobacteria in cyan. All nodes have >50 % bootstrap support (10,000 replicates).
b The GC-content of cas9 and the corresponding bacterial genome. Δ is the arithmetic difference between the cas9 and genome GC-contents; +/−
indicates whether cas9 has a lower (−) or higher (+) GC-content
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Conclusions
This study revealed for the first time presence of the
CRISPR-Cas system within the genus Bordetella, in a
genome of newly discovered B. pseudohinzii sp. nov.
We confirmed that this CRISPR-Cas system is actively
transcribed and its crRNAs are processed during bacter-
ial growth. Importantly, the CRISPR array carries spacer
sequences matching bacteriophages that infect this and
two most closely related B. hinzii species, thus, confer-
ring adaptive immunity in B. pseudohinzii against these
phages. The GC-content analysis of the CRISPR-cas
locus and homology searches of Cas9 protein sequences
explained how single species of Bordetella acquired this
system horizontally from yet an unknown source. The
most important observation made about this Bordetella
CRISPR-Cas system is its Cas9 endonuclease that is
different both in sequence and size from the endonucle-
ases commonly employed in the CRISPR-Cas technol-
ogy. While the smaller size of BpsuCas9 is of potential
utility for more efficient use of biological shuttle vectors
during transformations and viral transductions, the
unique sequence of BpsuCas9 might allow for some
alternative uses of these endonucleases, for example
and in addition to the genome editing and genome
engineering.
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